Eyenovia Inc. (EYEN): Analysis on the Earning Per Share


Eyenovia Inc. (NASDAQ:EYEN) changes shares on Tuesday trading session, with a change of -0.82% or -$0.03 shares. The trading starts at $3.70 and closed at $3.66 throughout the day. The trading session low price was $3.59 and day high was $3.70 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 56514.0 while its average volume is 124.43K. In other hand, the EYEN market cap reached to $76.12M.

On June 30, 2020, BRIEF-Eyenovia Resumes Recruitment Of Phase III Chaperone Study For Progressive Myopia. According to the news reported on Reuters, * EYENOVIA RESUMES RECRUITMENT OF PHASE III CHAPERONE STUDY FOR PROGRESSIVE MYOPIA Source text for Eikon: Further company coverage:

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -2.16% and up 27.82% for month. Its quarterly performance was 1.68% above, while its half year performance is down -16.91%. EYEN yearly performance stood at positive 13.44% and fall -18.97% for year-to-date. Current recommendation for Eyenovia Inc. is 1.50.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. EYEN EPS (TTM) for 12-month is -1.35. EPS for this year is 19.00%, while for the next year its value is -0.96. Its EPS Q/Q reached 36.70%.

Let’s take a look on the analyst recommendations on EYEN for the current month and previous month. For the current month, 3 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $6.00 – $19.00. Average target price for EYEN was reached at $13.00.

Uniplan Investment Counsel, Inc., Fairpointe Capital LLC and Vanguard Group, Inc. (The) are the top three holders in Eyenovia Inc. (EYEN) stock. On Mar 30, 2020, Uniplan Investment Counsel, Inc. has 0.61 million shares which valued 1.4 million. On Mar 30, 2020, Fairpointe Capital LLC owned 0.22 million shares which valued at 0.52 million. On Mar 30, 2020, Vanguard Group, Inc. (The) has a total of 0.2 million shares which valued at 0.47 million. In the end, Vanguard Group, Inc. (The) have 1.02% shares outstanding of Eyenovia Inc. (EYEN) on Mar 30, 2020. The insider ownership moved to 20.90% and institutional holding shifted to 6.60%.

The company posted an EPS (TTM) of -1.35. According to the most recent quarter report on (Jun 2020), 4 analysts estimated an average EPS of -0.25, while -0.44 EPS posted a year ago period. Analyst Estimated EPS for EYEN published in the report was -$0.31 – -$0.17 during the same period. Comparing with last year, the average estimated EPS was -0.44 which is lower than -0.31 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for EYEN rise 7.37% for period of 200 days. SMA for 50 days was 17.96% which is showing green signal, while SMA-20 was 12.65%. The moving average value for Eyenovia Inc. (EYEN) is 109.2k and 0.49% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in EYEN stock. On Mar 24, MARIO ERNEST, Director, bought 82,431 trading shares at the cost of $2.27, which valued at 0.19 million. On Mar 24, Ianchulev Tsontcho, Chief Executive Officer, bought 82,431 shares at the cost of $2.27, with total shares of 508,679. On Mar 23, Grant Stuart M., 10% Owner, bought 903,240 shares at the cost of 2.06. After this transaction, Grant Stuart M. total shares reached to 3,260,128 which valued at 1.86 million.